Gefitinib Tablets

Gefitinib Tablets are a form of medication classified as targeted therapy drugs, specifically designed to treat certain types of cancer. These tablets contain gefitinib as the active ingredient, which operates by blocking the epidermal growth factor receptor (EGFR). This receptor plays a critical role in the growth and propagation of cancer cells. By obstructing EGFR signaling, Gefitinib Tablets effectively impede the division and growth of cancer cells, thus slowing down or arresting the progression of the disease. This targeted approach offers a more precise and personalized treatment option compared to conventional chemotherapy. Administered orally, Gefitinib Tablets are convenient for patients to take.